1. Home
  2. CDNA vs BFLY Comparison

CDNA vs BFLY Comparison

Compare CDNA & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • BFLY
  • Stock Information
  • Founded
  • CDNA 1998
  • BFLY 2011
  • Country
  • CDNA United States
  • BFLY United States
  • Employees
  • CDNA N/A
  • BFLY N/A
  • Industry
  • CDNA Medical Specialities
  • BFLY Medical Electronics
  • Sector
  • CDNA Health Care
  • BFLY Health Care
  • Exchange
  • CDNA Nasdaq
  • BFLY Nasdaq
  • Market Cap
  • CDNA 1.1B
  • BFLY 1.1B
  • IPO Year
  • CDNA 2014
  • BFLY N/A
  • Fundamental
  • Price
  • CDNA $18.90
  • BFLY $2.53
  • Analyst Decision
  • CDNA Buy
  • BFLY Buy
  • Analyst Count
  • CDNA 8
  • BFLY 1
  • Target Price
  • CDNA $29.43
  • BFLY N/A
  • AVG Volume (30 Days)
  • CDNA 661.3K
  • BFLY 3.3M
  • Earning Date
  • CDNA 04-30-2025
  • BFLY 04-30-2025
  • Dividend Yield
  • CDNA N/A
  • BFLY N/A
  • EPS Growth
  • CDNA N/A
  • BFLY N/A
  • EPS
  • CDNA 0.93
  • BFLY N/A
  • Revenue
  • CDNA $333,785,000.00
  • BFLY $82,056,000.00
  • Revenue This Year
  • CDNA $13.33
  • BFLY $21.50
  • Revenue Next Year
  • CDNA $15.07
  • BFLY $25.34
  • P/E Ratio
  • CDNA $20.32
  • BFLY N/A
  • Revenue Growth
  • CDNA 19.07
  • BFLY 24.52
  • 52 Week Low
  • CDNA $7.42
  • BFLY $0.67
  • 52 Week High
  • CDNA $34.84
  • BFLY $4.98
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 50.38
  • BFLY 48.09
  • Support Level
  • CDNA $15.78
  • BFLY $2.01
  • Resistance Level
  • CDNA $20.13
  • BFLY $2.42
  • Average True Range (ATR)
  • CDNA 1.37
  • BFLY 0.21
  • MACD
  • CDNA 0.24
  • BFLY 0.07
  • Stochastic Oscillator
  • CDNA 71.72
  • BFLY 77.20

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Share on Social Networks: